Emiel Janssen
Emiel Janssen
Affiliazione sconosciuta
Email verificata su sus.no
Citata da
Citata da
Microsatellite instability in colorectal cancer
K S÷reide, EAM Janssen, H S÷iland, H K÷rner, JPA Baak
British journal of surgery 93 (4), 395-406, 2006
The X-linked gene G4. 5 is responsible for different infantile dilated cardiomyopathies
P D'Adamo, L Fassone, A Gedeon, EAM Janssen, S Bione, PA Bolhuis, ...
The American Journal of Human Genetics 61 (4), 862-867, 1997
X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)(MIM 302060)
PG Barth, RJA Wanders, P Vreken, EAM Janssen, J Lam, F Baas
Journal of inherited metabolic disease 22 (4), 555-567, 1999
De-novo mutation in hereditary motor and sensory neuropathy type I
JE Hoogendijk, GW Hensels, EAM Janssen, LJ Valentijn, F Baas, ...
The Lancet 339 (8801), 1081-1082, 1992
Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis
K Soreide, EA Janssen, H K÷rner, JPA Baak
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2006
Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder
MGW BOL, JANPA BAAK, S Buhr-Wildhagen, AJ Kruse, KH Kjellevold, ...
The Journal of urology 169 (4), 1291-1294, 2003
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers
JPA Baak, AJ Kruse, SJ Robboy, EAM Janssen, B van Diermen, I Skaland
Journal of clinical pathology 59 (10), 1017-1028, 2006
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer
E Gudlaugsson, I Skaland, EAM Janssen, R Smaaland, Z Shao, ...
Histopathology 61 (6), 1134-1144, 2012
Genomics and proteomics in cancer
JPA Baak, FRC Path, M Hermsen, G Meijer, J Schmidt, EAM Janssen
European Journal of Cancer 39 (9), 1199-1215, 2003
Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age
I Skaland, EAM Janssen, E Gudlaugsson, J Klos, KH Kjellevold, ...
Modern Pathology 20 (12), 1307-1315, 2007
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node–negative breast cancer patients younger than 55 years
JPA Baak, PJ van Diest, FJ Voorhorst, E van der Wall, LVAM Beex, ...
Journal of clinical oncology 23 (25), 5993-6001, 2005
Ki67 predicts progression in early CIN: validation of a multivariate progression‐risk model
AJ Kruse, J Baak, EA Janssen, KH Kjellevold, B Fiane, K Lovslett, J Bergh, ...
Analytical Cellular Pathology 26 (1, 2), 13-20, 2004
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
JPA Baak, E Gudlaugsson, I Skaland, LHR Guo, J Klos, TH Lende, ...
Breast cancer research and treatment 115 (2), 241-254, 2009
Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression
JPA Baak, B Van Diermen, A Steinbakk, E Janssen, I Skaland, GL Mutter, ...
Human pathology 36 (5), 555-561, 2005
Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability
AJ Kruse, I Skaland, EA Janssen, S Buhr-Wildhagen, J Klos, MJ Arends, ...
International journal of gynecological pathology 23 (2), 100-109, 2004
Low‐and high‐risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki‐67 immuno‐quantitative variables
AJ Kruse, JPA Baak, EA Janssen, MGW Bol, KH Kjellevold, B Fianne, ...
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2003
Local immune response in the microenvironment of CIN2–3 with and without spontaneous regression
IT ěvestad, E Gudlaugsson, I Skaland, A Malpica, AJ Kruse, ...
Modern pathology 23 (9), 1231-1240, 2010
Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region
LJ Hu, J Laporte, W Kress, P Kioschis, R Siebenhaar, A Poustka, ...
Human molecular genetics 5 (1), 139-143, 1996
Biologic profiling of lymph node negative breast cancers by means of microRNA expression
EAM Janssen, A Slewa, E Gudlaugsson, K Jonsdottir, I Skaland, ...
Modern Pathology 23 (12), 1567-1576, 2010
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous regression of CIN2–3
IT Ovestad, U Vennestr°m, L Andersen, E Gudlaugsson, AC Munk, ...
Gynecologic oncology 123 (2), 278-283, 2011
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20